Citrate buffer

DRUG2 trials

Sponsors

Eyegate Pharmaceuticals, Inc., Eli Lilly and Company

Conditions

HealthyHealthy Participants

Phase 1

Safety and Tolerability Study of Transscleral Iontophoresis by the EyeGate® II Drug Delivery Device System

CompletedNCT00698425

Eyegate Pharmaceuticals, Inc.Healthy

Start: 2008-03-31End: 2009-01-31Updated: 2010-08-23

A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants

CompletedNCT05154968

Eli Lilly and CompanyHealthy Participants

Start: 2021-11-24End: 2021-12-14Updated: 2022-01-13